In vivo studies also confirmed that knockdown of NEAT1 sensitized tumor cells to cisplatin/paclitaxel- or radio-induced tumor regression (An et al., 2017; Han et al., 2017; Hu et al., 2018). This evidence concerns the gene NEAT1 and neoplasm.